BioSpace News Archive

The COVID-19 vaccine candidate developed by Sanofi and GlaxoSmithKline hit a snag that will delay the launch of a Phase III study due to an insufficient immune response in older trial patients.

The U.S. Food and Drug Administration (FDA) has given the greenlight for V2ACT Therapeutics to proceed with a Phase I/IIa clinical trial of its investigational treatment for newly diagnosed surgically resectable pancreatic cancer.

Increase in the number of kaposi sarcoma patients in all worldwide locations is likely to fuel the growth of the global kaposi sarcoma diagnosis market during the assessment period of 2020 to 2030.

Advancements in oncological research is behind the increased demand within the global chemotherapy induced peripheral neuropathy market.

NANOBIOTIX, announced the pricing of its initial public offering on the Nasdaq Global Select Market by way of a capital increase of 7,300,000 new ordinary shares, consisting of a public offering of 5,445,000 ordinary shares in the form of American Depositary Shares, each representing the right to receive one ordinary share, in the United States and a concurrent offering of 1,855,000 ordinary shares in certain jurisdictions outside of the United States to certain investors.

Ohio State University’s Chief of Colon and Rectal Surgery joins Advisory Board at surgical intelligence startup focused on democratizing surgical care

Winning researchers and startup entrepreneurs capture prizes in four categories at Oregon Bio Digital 2020: Amplifying Diversity of Discovery, Access and Economics conference

The GP2 Phase III clinical trial design was presented during the 2020 San Antonio Breast Cancer Symposium (SABCS) and introduced by the Global Principal Investigator, Professor Mothaffar F. Rimawi of Baylor College of Medicine

Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to update the preliminary analysis of the Proxalutamide’s clinical trial for COVID-19.

Ra Medical Systems, Inc. (NYSE: RMED) announces the availability of its webcast event, The Inimitable Role of Excimer Lasers During the COVID-19 Pandemic, discussing the use of excimer lasers such as the Pharos excimer laser system for the treatment of psoriasis during the pandemic